What Are Incretin-Based Drugs, and What is the Problem With Them?

Incretins are metabolic hormones that work to regulate insulin secretion. Incretin therapies such as Janumet and Onglyza lower the level of blood sugar, thus prompting the body to produce insulin. However, studies over the past several years have shown incretin therapies for Type II diabetes may increase the risk for pancreatic cancer, a rapidly growing and deadly cancer that is difficult to... read more?